Table 1.

Characteristics of Persons With Plasmodium ovale Infection

Country (Province)	Survey Type, Year	Age	Sex	Fever	Symptoms	Original Diagnosis	RDT Result	Test Type Used	PCR Result	Treatment Received or Prescribed
Angola (Uige)	HF survey, 2016	15 mo	Female	Yes	Stomachache, weakness, headache	None	Negative	Pf/Pv RDT	Plasmodium ovale	Antipyretic
Angola (Uige)	HF survey, 2016	4 y	Male	Yes	Headache, stomachache, chills	Enteric disease	Negative	Pf/Pv RDT	P ovale	Antipyretic and an antibiotic
Angola (Uige)	HF survey, 2016	60 y	Female	Yes	Joint pain, headache, lack of appetite	None	Negative	Pf/Pv RDT	P ovale	Antipyretic and an antibiotic
Mozambique (Maptuo)	HF survey, 2018	23 y	Female	No	Chills, weakness, joint pain, headache	None	Negative	Pf RDT	P ovale	Antipyretic and albendazole
Mozambique (Zambezia)	HF survey, 2018	4 y	Female	Yes	Headache, vomiting	None	Negative	Pf RDT	P ovale	Antipyretic and an antibiotic
Mozambique (Zambezia)	HF survey, 2018	45 y	Female	Yes	Headache, joint pain, backache	None	Negative	Pf RDT	P ovale	Antipyretic and an antibiotic
Mozambique (Zambezia)	HF survey, 2018	15 y	Male	Yes	Headache	None	Negative	Pf RDT	P ovale + Plasmodium falciparum	Antipyretic and an antibiotic
Ethiopia (Amhara)	TES, 2017	15 y	Male	Yes	Unknown	Plasmodium vivax malaria	Negative	Microscopy, Pf/Pv RDT	P ovale	Chloroquine and 14-d primaquine

Abbreviations: HF, health facility; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; RDT, rapid diagnostic test; TES, therapeutic efficacy study.